About Us Code of Business Conduct and Ethics Second Amended and Restated Introduction The Board of Directors of Harvard Bioscience, Inc. (together with its subsidiaries, “the Company”) established this Code of Business Conduct and Ethics to: (a) promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest; (b) promote full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with, submits to, the Securities and Exchange Commission and in other public communications made by the Company; (c) promote compliance with applicable governmental laws, rules and regulations; (d) promote the protection of the Company’s assets, including corporate opportunities and confidential information; (e) promote fair dealing practices; (f) deter wrongdoing; and (g) ensure accountability for adherence to this Code. The Company’s Board of Directors or a committee of the Board is responsible for administering the Code. The Board of Directors has delegated day-to-day responsibility for administering and interpreting the Code to a Compliance Officer. Our Chief Financial Officer has been appointed the Company’s Compliance Officer under this Code. The Company expects its directors, officers and employees to exercise reasonable judgment when conducting the Company’s business. The Company encourages its directors, officers and employees to refer to this Code frequently to ensure that they are acting within both the letter and the spirit of this Code. The Company also understands that this Code will not contain the answer to every situation you may encounter or every concern you may have about conducting the Company’s business ethically and legally. In these situations, or if you otherwise have questions or concerns about this Code, the Company encourages each officer and employee to speak with his or her supervisor (if applicable) or, if you are uncomfortable doing that, with the Compliance Officer under this Code. << Download the entire Code of Conduct >>. © 2021 Harvard Bioscience All rights reserved Privacy Policy Terms & Conditions Site Map

Skip to main navigation Investor Relations Email Alert Subscription Symbol: Open High | Low Volume Data Provided by Refinitiv. Minimum 15 minutes delayed. Contact Us HBIO Investor Presentation – May 2021 You may automatically receive Harvard Bioscience, Inc. financial information by email. Please enter your preferences for email notifications below and click submit. Required fields denoted by an asterisk (). Alert Type Quote By Email All SEC Filings Insider Transactions Press Releases Weekly Summary Email Unsubscribe from Investor Relations email alerts. Our email alerts provide automated opt-out methods as well as complete contact information. Shareholder Tools © 2021 Harvard Bioscience, Inc. All rights reserved Privacy Policy. Terms & Conditions Site Map